Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Valve Stenosis | 13 | 2022 | 354 | 1.390 |
Why?
|
| Transcatheter Aortic Valve Replacement | 12 | 2022 | 224 | 1.280 |
Why?
|
| Heart Valve Prosthesis | 8 | 2021 | 303 | 0.870 |
Why?
|
| Heart Valve Prosthesis Implantation | 7 | 2022 | 440 | 0.810 |
Why?
|
| Aortic Valve | 10 | 2022 | 460 | 0.600 |
Why?
|
| Interleukin-17 | 2 | 2011 | 128 | 0.400 |
Why?
|
| Postoperative Complications | 8 | 2021 | 3113 | 0.390 |
Why?
|
| Intestinal Mucosa | 3 | 2011 | 764 | 0.350 |
Why?
|
| Chemokine CCL20 | 1 | 2011 | 17 | 0.350 |
Why?
|
| Colon | 2 | 2011 | 360 | 0.340 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2011 | 55 | 0.330 |
Why?
|
| Nerve Regeneration | 1 | 2011 | 76 | 0.330 |
Why?
|
| Interleukins | 1 | 2011 | 121 | 0.320 |
Why?
|
| Epithelium, Corneal | 2 | 2011 | 174 | 0.320 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2011 | 199 | 0.320 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 341 | 0.290 |
Why?
|
| Bioprosthesis | 2 | 2020 | 112 | 0.280 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2020 | 152 | 0.250 |
Why?
|
| Cornea | 1 | 2011 | 566 | 0.250 |
Why?
|
| Stroke | 3 | 2021 | 1049 | 0.210 |
Why?
|
| Neutrophils | 3 | 2022 | 372 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2011 | 31 | 0.170 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2011 | 119 | 0.170 |
Why?
|
| P-Selectin | 2 | 2011 | 69 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 9 | 2011 | 4763 | 0.160 |
Why?
|
| Inflammation | 4 | 2011 | 1490 | 0.160 |
Why?
|
| Prosthesis Failure | 1 | 2020 | 148 | 0.160 |
Why?
|
| Disease Susceptibility | 2 | 2011 | 283 | 0.150 |
Why?
|
| Colitis | 2 | 2011 | 159 | 0.150 |
Why?
|
| Weight Loss | 3 | 2011 | 513 | 0.140 |
Why?
|
| Blood Platelets | 2 | 2011 | 315 | 0.140 |
Why?
|
| Wound Healing | 2 | 2011 | 476 | 0.130 |
Why?
|
| Mice, Knockout | 5 | 2011 | 3861 | 0.130 |
Why?
|
| Treatment Outcome | 11 | 2022 | 12936 | 0.130 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 6916 | 0.130 |
Why?
|
| Mice | 10 | 2011 | 18473 | 0.120 |
Why?
|
| DNA Methylation | 3 | 2011 | 1085 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2019 | 423 | 0.110 |
Why?
|
| Risk Factors | 8 | 2022 | 10952 | 0.110 |
Why?
|
| Epigenesis, Genetic | 2 | 2011 | 749 | 0.110 |
Why?
|
| Health Care Rationing | 1 | 2015 | 59 | 0.110 |
Why?
|
| Cardiac Catheterization | 2 | 2016 | 635 | 0.110 |
Why?
|
| Obesity | 3 | 2011 | 2379 | 0.110 |
Why?
|
| Registries | 2 | 2022 | 1599 | 0.100 |
Why?
|
| CD11c Antigen | 2 | 2011 | 40 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 837 | 0.100 |
Why?
|
| Survival Rate | 4 | 2021 | 2149 | 0.090 |
Why?
|
| Atrial Fibrillation | 2 | 2019 | 732 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 792 | 0.090 |
Why?
|
| Dietary Fats | 2 | 2010 | 276 | 0.090 |
Why?
|
| Animals | 10 | 2011 | 34341 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2022 | 3090 | 0.090 |
Why?
|
| Receptors, CCR6 | 1 | 2011 | 6 | 0.090 |
Why?
|
| Chemokine CXCL1 | 1 | 2011 | 15 | 0.090 |
Why?
|
| Patient Selection | 1 | 2015 | 723 | 0.090 |
Why?
|
| Genes, T-Cell Receptor delta | 1 | 2011 | 8 | 0.090 |
Why?
|
| Adipose Tissue | 2 | 2011 | 494 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 1236 | 0.090 |
Why?
|
| Monocytes | 2 | 2011 | 337 | 0.090 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2010 | 26 | 0.080 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2011 | 50 | 0.080 |
Why?
|
| Male | 15 | 2021 | 65158 | 0.080 |
Why?
|
| Anti-Obesity Agents | 1 | 2010 | 46 | 0.080 |
Why?
|
| Time Factors | 5 | 2021 | 6273 | 0.080 |
Why?
|
| Metabolic Syndrome | 2 | 2011 | 362 | 0.080 |
Why?
|
| Bacteria | 2 | 2011 | 532 | 0.080 |
Why?
|
| Metagenome | 1 | 2011 | 143 | 0.080 |
Why?
|
| Epigenomics | 1 | 2011 | 186 | 0.080 |
Why?
|
| Intra-Abdominal Fat | 1 | 2009 | 64 | 0.080 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2011 | 386 | 0.070 |
Why?
|
| Piperidines | 1 | 2010 | 232 | 0.070 |
Why?
|
| Computational Biology | 2 | 2011 | 872 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 421 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2011 | 232 | 0.070 |
Why?
|
| Leukocytes | 1 | 2009 | 211 | 0.070 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 5277 | 0.070 |
Why?
|
| Skin | 1 | 2011 | 553 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2011 | 2567 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 2 | 2011 | 1745 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 469 | 0.070 |
Why?
|
| Female | 12 | 2021 | 71087 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 1313 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2010 | 358 | 0.070 |
Why?
|
| Humans | 18 | 2022 | 131504 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2011 | 453 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2010 | 536 | 0.060 |
Why?
|
| Echocardiography | 3 | 2017 | 1138 | 0.060 |
Why?
|
| Canada | 2 | 2019 | 327 | 0.060 |
Why?
|
| Liver | 2 | 2011 | 1795 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2011 | 900 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2011 | 328 | 0.060 |
Why?
|
| Aged | 6 | 2021 | 21238 | 0.060 |
Why?
|
| Chemokine CCL2 | 3 | 2011 | 114 | 0.060 |
Why?
|
| Models, Biological | 1 | 2011 | 1390 | 0.060 |
Why?
|
| Prosthesis Design | 2 | 2019 | 610 | 0.060 |
Why?
|
| Incidence | 3 | 2017 | 3344 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 1078 | 0.050 |
Why?
|
| United States | 5 | 2019 | 11794 | 0.050 |
Why?
|
| Length of Stay | 2 | 2019 | 1393 | 0.040 |
Why?
|
| Sternotomy | 1 | 2021 | 42 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 2355 | 0.040 |
Why?
|
| Blood Cell Count | 2 | 2011 | 64 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2022 | 359 | 0.040 |
Why?
|
| Quality of Life | 2 | 2021 | 2107 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2017 | 109 | 0.030 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2017 | 80 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2017 | 3693 | 0.030 |
Why?
|
| British Columbia | 1 | 2016 | 10 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2017 | 6485 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2016 | 99 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1522 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2016 | 135 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2016 | 300 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 409 | 0.030 |
Why?
|
| Medical Futility | 1 | 2015 | 41 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 510 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 265 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 359 | 0.030 |
Why?
|
| Benchmarking | 1 | 2015 | 138 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 463 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 1405 | 0.020 |
Why?
|
| Isomerism | 1 | 2011 | 25 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2011 | 37 | 0.020 |
Why?
|
| Elasticity | 1 | 2011 | 93 | 0.020 |
Why?
|
| Betaine | 1 | 2011 | 19 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1254 | 0.020 |
Why?
|
| Choline | 1 | 2011 | 51 | 0.020 |
Why?
|
| Vitamin B 12 | 1 | 2011 | 59 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 57 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2011 | 106 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 221 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2015 | 1075 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2009 | 35 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2009 | 64 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2011 | 263 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 824 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 226 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 4684 | 0.020 |
Why?
|
| Chemokines | 1 | 2009 | 127 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2011 | 215 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2009 | 90 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 2009 | 78 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 609 | 0.020 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2011 | 152 | 0.020 |
Why?
|
| Folic Acid | 1 | 2011 | 288 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 4951 | 0.020 |
Why?
|
| Weight Gain | 1 | 2010 | 383 | 0.020 |
Why?
|
| Energy Intake | 1 | 2010 | 501 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 769 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1610 | 0.020 |
Why?
|
| Pedigree | 1 | 2011 | 1710 | 0.020 |
Why?
|
| Cell Movement | 1 | 2010 | 879 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1487 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2009 | 678 | 0.010 |
Why?
|
| Diet | 1 | 2010 | 1119 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 2870 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 10092 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 3452 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 1788 | 0.010 |
Why?
|
| Biomarkers | 1 | 2009 | 3403 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 17648 | 0.010 |
Why?
|
| Pregnancy | 1 | 2011 | 7572 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 28839 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 31666 | 0.010 |
Why?
|